Sugammadex and Menstrual Cycle in Postoperative Nausea and Vomiting

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorSakarya University

About this trial

This observational study aims to evaluate the relationship between menstrual cycle phases and the incidence of postoperative nausea and vomiting (PONV) in women of reproductive age undergoing septorhinoplasty surgery. The study's primary objective is to determine whether different phases of the menstrual cycle are associated with variations in PONV frequency. As a secondary objective, the relationship between menstrual phases, PONV incidence, and the use of sugammadex during anesthesia will be analyzed. No additional intervention will be applied beyond routine clinical practice; all data will be collected prospectively from anesthesia records and postoperative evaluations.

Eligibility criteria

Qualifiers

Female sex

Age between 18 and 40 years

Regular menstrual cycle

Scheduled for ENT (ear, nose, and throat) surgery

Disqualifiers

Irregular menstrual cycle

Unknown date of last menstrual period

Receiving estrogen and/or progesterone supplementation

Pre-menopausal or menopausal status

Trial design

Treatments tested in this trial

  • PONV Assessment Questionnaire

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators